Replies to post #760 on Trillium Therapeutics Inc (TRIL)

[vinmantoo]

Day Traders getting out likely. It doesn't matter compliance news is approaching Wednesday. After that I expect take off, also partnership for CD47 products or STING lined up.

Exactly. If TRIL closes over $1 on wednesday, the threat of delisting is gone. I have no problem with day traders, but I hate when they clutter up the board with their repetitive nonsense. A partnership with some really nice up front cash would be great but I sure hope management doesn't sell TRIL short.

Presentation slides mentioned STING out licensing expected 1st half 2020. TRIL going higher.

I too expect TRIL to go higher, especially if FTSV trial data with the anti-CD47 drug combo trial continues to show positive data before TRIL's TTI-621 trial reports new data. FTSV doesn't have a cash shortage but TRIL does. Therefore, if TRIL keeps rising I expect some sort of stock issuance to raise some much needed cash. Being in a stronger financial position will enhance their bargaining position if some company decides they want to partner with TRIL.